SMTL ID : 2qu5.1

Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.95 Å

Oligo State

monomer

Ligands

1 x 276: 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide(Non-covalent)

276.1: 23 residues within 4Å: Chain A: L.26, V.34, A.52, K.54, E.71, I.74, L.75, I.78, V.84, V.85, T.102, E.103, F.104, C.105, K.106, G.108, L.155, H.162, L.171, I.180, C.181, D.182, F.183 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.26, A:V.34, A:K.54, A:E.71, A:L.75, A:L.75, A:V.84, A:V.85, A:T.102, A:L.171, A:F.183 Hydrogen bonds: A:E.71, A:C.105, A:C.105, A:D.182 pi-Cation interactions: A:K.54

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Potashman, M.H. et al., Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors. J.Med.Chem. (2007)

Release Date

2007-09-25

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence